Skip to content

A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.

A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.

Published on

Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.

Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

Published on

Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.

Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.

Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.

Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.

Published on

Stanford Medicine researchers are investigating SARS-CoV-2 to address the COVID-19 pandemic and ultimately help restore normalcy to society.

Stanford Medicine researchers are investigating SARS-CoV-2 to address the COVID-19 pandemic and ultimately help restore normalcy to society.

Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.

Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.

Published on

Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.

Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.

Published on

A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.

A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.

In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.

In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.

At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.

At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.

Published on